Literature DB >> 28035203

The Possible Association Between DAA Treatment for HCV Infection and HCC Recurrence.

Brown Robert S1.   

Abstract

Entities:  

Year:  2016        PMID： 28035203      PMCID： PMC5193084     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolution.

Authors:  Jean-Charles Nault; Massimo Colombo
Journal:  J Hepatol       Date:  2016-07-12       Impact factor: 25.083

2.  Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma.

Authors:  Ju Dong Yang; Bashar A Aqel; Surakit Pungpapong; Gregory J Gores; Lewis R Roberts; Michael D Leise
Journal:  J Hepatol       Date:  2016-07-05       Impact factor: 25.083

3.  Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.

Authors:  María Reig; Zoe Mariño; Christie Perelló; Mercedes Iñarrairaegui; Andrea Ribeiro; Sabela Lens; Alba Díaz; Ramón Vilana; Anna Darnell; María Varela; Bruno Sangro; José Luis Calleja; Xavier Forns; Jordi Bruix
Journal:  J Hepatol       Date:  2016-04-13       Impact factor: 25.083

4.  Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts.

Authors: 
Journal:  J Hepatol       Date:  2016-06-07       Impact factor: 25.083
  4 in total
  9 in total

Review 1.  Potential Liver Transplant Recipients with Hepatitis C: Should They Be Treated Before or After Transplantation?

Authors:  Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2017-02-06

Review 2.  Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals.

Authors:  Loraine Kay D Cabral; Luca Grisetti; Muhammad Yogi Pratama; Claudio Tiribelli; Devis Pascut
Journal:  Cancers (Basel)       Date:  2022-05-30       Impact factor: 6.575

3.  Occurrence and Recurrence of Hepatocellular Carcinoma After Successful Direct-Acting Antiviral Therapy for Patients With Chronic Hepatitis C Virus Infection.

Authors:  Sirisha Grandhe; Catherine T Frenette
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-07

4.  The frequency of occurrence of Hepatocellular Carcinoma after direct antiviral therapy in Hepatitis C virus patients.

Authors:  Bilal Aziz; Tazeen Nazar; Suhair Akhlaq
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

5.  Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study.

Authors:  Luca Rinaldi; Alessandro Perrella; Maria Guarino; Massimo De Luca; Guido Piai; Nicola Coppola; Pia Clara Pafundi; Fortunato Ciardiello; Morena Fasano; Erika Martinelli; Giovanna Valente; Riccardo Nevola; Caterina Monari; Lucia Miglioresi; Barbara Guerrera; Massimiliano Berretta; Ferdinando Carlo Sasso; Filomena Morisco; Antonio Izzi; Luigi Elio Adinolfi
Journal:  J Transl Med       Date:  2019-08-28       Impact factor: 5.531

6.  Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients.

Authors:  Magdy Fouad; Mohamed El Kassas; Elham Ahmed; Reem El Sheemy
Journal:  World J Hepatol       Date:  2021-11-27

7.  Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients.

Authors:  Reham M Dawood; Mai Abd El-Meguid; Hend Ibrahim Shousha; Ahmed Elsayed; Mohamed Mahmoud Nabeel; Ayman Yosry; Ashraf Abdelaziz; Ghada M Salum
Journal:  Heliyon       Date:  2022-08-08

8.  Effect of Hepatocellular Carcinoma on Mortality Among Individuals With Hepatitis B or Hepatitis C Infection in New York City, 2001-2012.

Authors:  Miranda S Moore; Angelica Bocour; Olivia C Tran; Baozhen Qiao; Maria J Schymura; Fabienne Laraque; Ann Winters
Journal:  Open Forum Infect Dis       Date:  2018-06-16       Impact factor: 3.835

Review 9.  Direct antiviral agents for HCV infection and hepatocellular carcinoma: facts and FADs.

Authors:  Ilaria Serio; Lucia Napoli; Simona Leoni; Fabio Piscaglia
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.